The use of abciximab during percutaneous coronary angioplasty reduces ischaemic events, but the cost is prohibitive.
作者信息
Mayosi B M, Latouf S E, Commerford P J
出版信息
S Afr Med J. 1998 Feb;88(2):130-1.
PMID:9717492
Abstract
摘要
Mayosi B M, Latouf S E, Commerford P J
S Afr Med J. 1998 Feb;88(2):130-1.
Zotero 插件